CNS Summit 2024

With an approval rate for neuroscience therapies that is about half that for other drugs, the distinct challenges of clinical research in this area – accelerating recruitment, measuring highly subjective endpoints, countering placebo effects, demonstrating clinical meaningful efficacy – need to be met with an uncommon blend of scientific depth and elegant problem-solving.  

Syneos Health will be on the ground at CNS Summit, showcasing our deep clinical neuroscience and psychiatry expertise, focus on site and patient excellence and application of cutting-edge innovation and artificial intelligence to clinical development—all combining to deliver fit-for-purpose solutions customized to your specific neuroscience asset development needs.

Will you be at CNS Summit? Meet with our team at booth #811 to learn more about how we can help you overcome your next neuroscience challenge.

Related Content

Want to learn more? Explore Insights Hub for our latest perspectives,  subscribe to our podcast, or click the resources below:  

Understanding the Role of the Placebo Response in Clinical Trials​

Syneos Health Podcast | World Mental Health Day: The State of Mental Health Clinical Development​

ON DEMAND WEBINAR | Psychedelics 3.0: Drug Development Challenges and Opportunities in a Rapidly Evolving Field​

Syneos Health Podcast | Can AI Help Get the Right Patients Into Alzheimer's Clinical Trials?​

Artificial Intelligence and Alzheimer’s: Transforming Patient Screening with Predictive Models

Our Capabilities:

Neuroscience: Experience and Expertise to Accelerate Drug Development Success​

Psychotherapeutics: Psychedelics & Entactogens | Helping to Unlock Potential Therapeutic Impact for Patients in Need​

Revolutionizing Psychiatry Clinical Trials and Treatment​

Transforming the Outlook on Depressive Disorders​

StudyKIK CarePackage™​

StudyKIK PatientConnect​

StudyKIK StudyCash

Complete the form below to request a meeting with our team.